To examine prospectively the relation between alcohol consumption and pancreatic cancer risk, the authors analyzed data from the Netherlands Cohort Study. Participants were 120,852 persons who completed a baseline questionnaire in 1986. After 13.3 years of follow-up, 350 cases of pancreatic cancer (67% microscopically confirmed) were available for analysis. Compared with abstention, the highest category of alcohol consumption (!30 g/day of ethanol) was positively associated with pancreatic cancer risk (for all cases, rate ratio ¼ 1.57, 95% confidence interval: 1.03, 2.39; P trend ¼ 0.12; for microscopically confirmed cases, rate ratio ¼ 1.54, 95% confidence interval: 0.94, 2.54; P trend ¼ 0.22). In a subgroup of stable alcohol users (no change during the 5 years before baseline), a similarly increased risk of pancreatic cancer was found. This increased risk was limited to the first 7 years of follow-up. No associations were observed between consumption of specific alcoholic beverages and risk of pancreatic cancer. The associations were not modified by folate intake or smoking. Overall, these findings suggest an increased pancreatic cancer risk for persons with a high ethanol intake (!30 g/day). However, this increased risk was observed only during the first 7 years of follow-up. alcohol drinking; alcoholic beverages; beer; cohort studies; ethanol; pancreatic neoplasms; wine Abbreviations: CI, confidence interval; MCPC, microscopically confirmed pancreatic cancer; RR, rate ratio.
Pancreatic cancer is among the most fatal cancers worldwide, with a 5-year survival rate of 6% or less (1, 2) . Since there is no effective way to screen for this malignancy, prevention could have a major impact on pancreatic cancer mortality. So far, cigarette smoking, diabetes mellitus, and body fatness have been identified as risk factors (3) (4) (5) .
There is evidence that chronic alcohol consumption may alter pancreatic function (6) , which may predispose people to pancreatic cancer. Several mechanisms have been suggested. First, heavy alcohol consumption is a known risk factor for chronic pancreatitis (3, 7) , which has been linked to pancreatic cancer (8, 9) . In addition, evidence suggests that the metabolites generated during metabolism of alcohol (e.g., acetaldehyde) may be carcinogenic (3, 10, 11) . Furthermore, the effects of alcohol may be mediated through the generation of free-radical oxygen species which can lead to DNA damage (11) .
Eight cohort studies have found no association between alcohol consumption and pancreatic cancer risk (12) (13) (14) (15) (16) (17) (18) . Seven cohort studies have found an increased risk (19) (20) (21) (22) (23) (24) (25) , but results were statistically significant in only 2 (22, 25) . Inconsistent findings have also been obtained in the numerous case-control studies that have been conducted (3) . Recently, the second World Cancer Research Fund/ American Institute for Cancer Research expert report concluded that low-to-moderate levels of alcohol consumption were unlikely to have an effect on pancreatic cancer risk, but the possibility could not be excluded that heavy drinking might have an effect (3) .
Our aim in this study was to investigate the association between alcohol consumption and the risk of pancreatic cancer in a large prospective cohort study in the Netherlands. Furthermore, we investigated whether the association between pancreatic cancer risk and alcohol consumption was modified by smoking status or folate intake.
MATERIALS AND METHODS

Study population and cancer follow-up
The design of the Netherlands Cohort Study has been reported in detail elsewhere (26) . Briefly, the study was begun in September 1986 and included initially 58,279 men and 62,573 women aged 55-69 years from 204 Dutch municipalities with computerized population registries. A self-administered questionnaire on potential risk factors for cancer was completed at baseline. For increased efficiency in the processing of the questionnaire (which was very detailed and of which only the first page could be optically scanned) and follow-up, the case-cohort approach (27) was used. Case subjects were derived from the entire cohort, whereas person-years at risk were estimated from a random sample of 5,000 subjects. This subcohort was chosen immediately after baseline and was followed up for vital status information. The entire cohort is being monitored for cancer occurrence through annual record linkage with the Netherlands Cancer Registry and the Netherlands Pathology Registry (28) . For the current analyses, follow-up was restricted to the period from baseline to December 1999, a total of 13.3 years. Only 2 subcohort members were lost to follow-up, and completeness of follow-up was estimated to be greater than 96% (29) .
For cases and subcohort members, all persons with prevalent cancer (other than nonmelanoma skin cancer) at baseline were excluded (n ¼ 226). Of the 447 incident cases of pancreatic cancer, persons with endocrine subtypes (isletcell carcinoma; n ¼ 1) were excluded. Additionally, subjects with incomplete or inconsistent dietary data (336 subcohort members, 38 cases) and subjects with incomplete alcohol data (130 subcohort members, 13 cases) were excluded from analyses. Details are given elsewhere (30) . Alcohol data were considered incomplete when all questions on the consumption frequency of alcoholic beverages were left blank and 2 questions on alcohol consumption pattern did not indicate that the subject was an abstainer. These 2 questions concerned alcohol intake during the past week and 5 years previously.
The Netherlands Cohort Study protocol has been approved by the institutional review boards of the TNO Nutrition and Food Research Institute (Zeist, the Netherlands) and Maastricht University (Maastricht, the Netherlands).
Questionnaire
The dietary section of the baseline questionnaire was a 150-item semiquantitative food frequency questionnaire, which concentrated on habitual consumption during the year preceding the start of the study. Alcohol consumption was measured by assessing 6 items: beer; red wine; white wine; sherry and other fortified wines; liqueurs containing, on average, 16% ethanol; and (Dutch) gin, brandy, and whiskey. Total mean daily ethanol intake was calculated using the Dutch food composition table (31) . Data on the folate content of foods were derived from a validated liquid chromatography trienzyme method (32) used to analyze the 125 most important Dutch foods contributing to folate intake (33) .
We defined low alcohol consumption as drinking >0-10 g/day of ethanol; moderate consumption as drinking >10-<30 g/day; and high consumption as drinking !30 g/ day. The definition of a standard glass of an alcoholic beverage used in the Netherlands is a beverage that contains approximately 10 g of ethanol (34) .
One question on the questionnaire requested information on the subject's drinking habits 5 years before baseline. For beer and for ''other alcoholic beverages,'' the subject could indicate whether, 5 years before baseline, he or she had consumed 1) more than at baseline, 2) equal amounts as at baseline, or 3) less than at baseline, or 4) never used those beverages.
The food frequency questionnaire had been validated and tested for reproducibility (30, 35) . For mean daily alcoholic beverage intake, the Spearman correlation coefficients for correlations between the 9-day diet record and the questionnaire were 0.89 for all subjects and 0.85 for users of alcoholic beverages (30) . The absolute amount of ethanol reported in the questionnaire by users of alcoholic beverages was, on average, 86% of that reported in the 9-day diet record (30) .
Statistical analysis
Age-adjusted and multivariable-adjusted incidence rate ratios and corresponding 95% confidence intervals were estimated using Cox proportional hazards models. The total person-years at risk estimated from the subcohort were used in the analyses (36) . We estimated standard errors using the robust Huber-White sandwich estimator to account for the additional variance introduced by sampling from the cohort (37) . We tested the proportional hazards assumption using the scaled Schoenfeld residuals (38) . In case the proportional hazards assumption was violated with respect to alcohol consumption, we performed a test for interaction between alcohol consumption and time, and we stratified the follow-up period into 2 periods (<7 years and !7 years, according to the midpoint) to investigate further how risk estimates changed during follow-up. Analyses were conducted for both sexes combined and separately for men and women.
Rate ratios were estimated for categories of ethanol intake, with the abstainers regarded as the reference group. Respondents who consumed alcoholic beverages less than once per month were considered abstainers. In addition to considering the total amount of ethanol intake, we examined 3 types of alcoholic beverages-beer, wine (red wine, white wine, sherry, and other fortified wines), and liquor (liqueurs, gin, brandy, and whiskey)-relative to nondrinkers of beer, wine, and liquor, respectively. Total ethanol intake was divided into 5 categories: abstention (0 g/day) and consumption of 0.1-<5, 5-<15, 15-<30, and !30 g/day. For beer, wine, and liquor, categories included nonuser and 0.1-<1, 1-<5, and !5 glasses/week. Rate ratios were also estimated for continuous exposures, which we report in representative serving sizes; that is, for total ethanol intake, an increment of 10 g/day was used, and for the specific alcoholic beverages, an increment of 1 glass/day was used. On the basis of pilot study data, standard glass sizes were defined as 200 mL for beer, 105 mL for wine, and 45 mL for liquor, corresponding to 8 g, 10 g, and 13 g of ethanol, respectively (39) .
Besides age and sex, we included smoking in the multivariable-adjusted model, since this is a strong risk factor for pancreatic cancer (8) . Other variables examined as potential confounders included body mass index (weight (kg)/height (m)
2 ), energy intake, intakes of vegetables and fruit, level of education, nonoccupational moderate physical Abbreviation: SD, standard deviation. a A random sample of 5,000 subjects from the cohort chosen immediately after baseline and followed up for vital status information for estimation of the person-years in the entire cohort.
b Stable drinkers were defined as subjects who reported consuming equal total amounts of alcohol 5 years before baseline and at baseline.
c Energy-adjusted intake. activity, multivitamin use, family history of pancreatic cancer, history of diabetes mellitus, hypertension, cholecystectomy, gallstones, and gastric ulcer. These confounding variables were added to the multivariable-adjusted model if they 1) were associated with the disease and with ethanol intake and 2) changed the risk estimate by at least 10%. This resulted in a multivariable-adjusted model that included age at baseline (years), sex, cigarette smoking (smoking status (current smoking: yes/no); number of cigarettes smoked per day by current and ex-smokers; number of years of smoking for current and ex-smokers), body mass index, total energy intake (kcal/day), and vegetable and fruit intakes (g/day). We additionally adjusted analyses for beer, wine, and liquor for total ethanol intake (g/day) to evaluate the effect of each beverage on pancreatic cancer risk independently of the beverage's alcohol content.
To permit comparison, we restricted age-adjusted analyses to subjects included in multivariable-adjusted analyses, which left 3,980 subcohort members (1,954 men and 2,026 women) and 350 exocrine pancreatic cancer cases (185 men and 165 women) for analyses. Sixty-seven percent of these pancreatic cancer cases were microscopically confirmed pancreatic cancer (MCPC) (n ¼ 234), whereas confirmation was lacking for 33% (n ¼ 116). Diagnosis of the latter group was made by the treating clinician and was based on clinical symptoms, physical examination, and imaging results, and data were abstracted and recorded by a trained tumor registrar (40) .
For each analysis, we evaluated trends with the Wald test by assigning participants the median value for each level of the categorical exposure variable among the subcohort members, and this variable was entered as a continuous term in the Cox regression model. To evaluate whether the association between alcohol consumption and pancreatic cancer risk was linear, we examined nonparametric regression curves using restricted cubic splines, using different numbers and positions of knots (41, 42) . Testing the need for nonlinear terms in the models was done using the Wald v 2 statistic. In the present study, the overall analyses were conducted on all pancreatic cancer cases. We restricted additional analyses to MCPC cases in order to create a group with a higher degree of diagnostic certainty of pancreatic cancer, which was shown to be important in a previous study (43) .
Since early symptoms of disease may cause subjects to stop drinking alcohol or to continue their drinking at a lower level, baseline measurement of alcohol intake alone will categorize these drinkers as abstainers or low-level drinkers. This will result in underestimated disease risk. In additional analyses, we evaluated the relation between alcohol consumption and pancreatic cancer risk by restricting the analyses to alcohol drinkers who reported having consumed the same amount of alcohol 5 years before baseline as they did at baseline, using as a reference category the abstainers at baseline who reported having also abstained from alcohol use 5 years before baseline. Hereafter, we refer to this subgroup as stable alcohol users. In addition, we restricted the analyses to alcohol drinkers who reported having consumed more alcohol or less alcohol 5 years before baseline as compared with baseline, using the same reference category as for the analysis in stable alcohol users. Heavy consumers of alcohol may have a reduced folate status, making the pancreas susceptible to carcinogenesis (3, 6) . In addition, it has been suggested that alcohol and tobacco enhance each other's effects (44) . Therefore, interactions between ethanol intake and cigarette smoking (never smoking, ex-smoking, a A random sample of 5,000 subjects from the cohort chosen immediately after baseline and followed up for vital status information for estimation of the person-years in the entire cohort.
b Heavy users were defined as subjects who consumed !30 g of ethanol per day.
current smoking) were investigated, as well as interactions between alcohol consumption and dietary folate intake (low and high intakes based on sex-specific median folate intake (212 lg/day for men and 187 lg/day for women)). All analyses were performed using the STATA statistical software package (45) . All P values were based on 2-sided tests and were considered statistically significant if they were less than 0.05.
RESULTS
At baseline, 79% of the pancreatic cancer cases consumed alcohol. As Table 1 shows, most baseline characteristics did not differ noticeably between pancreatic cancer cases and subcohort members, but there were more diabetics and smokers among pancreatic cancer cases than among subcohort members. Table 2 shows the percentages of abstainers and heavy alcohol users (!30 g/day of ethanol) according to drinking habits, which did not differ noticeably between pancreatic cancer cases and subcohort members.
In a comparison of the highest category of ethanol intake (!30 g/day) with abstention, the age-adjusted rate ratio for pancreatic cancer was 1.83 (95% confidence interval (CI): 1.24, 2.71) ( Table 3 ). The P value from the trend test was significant (P trend ¼ 0.01), but there was no clear doseresponse relation. When we repeated the analyses with adjustment for confounding variables, the risk estimate was attenuated but still significant (rate ratio (RR) ¼ 1.57, 95% CI: 1.03, 2.39), again with no clear dose-response relation (P trend ¼ 0.12). When we restricted the analyses to MCPC cases, the point estimate remained similar but became nonsignificant (Table 3) . No significantly increased risk of pancreatic cancer was found per 10-g/day increment of ethanol intake in the continuous analyses. After stratification by sex (data not shown), we observed a significantly increased risk for men (heavy alcohol consumers vs. abstainers: RR ¼ 1.82, 95% CI: 1.03, 3.23), but for women Abbreviations: CI, confidence interval; RR, rate ratio. a Median intake in subcohort (see Table 1 for definition of subcohort). b Adjusted for age (years), sex, smoking (smoking status (current smoking: yes/no); number of cigarettes smoked per day; number of years of smoking), energy intake (kcal/day), body mass index (weight (kg)/height (m) 2 ), vegetable intake (g/day), and fruit intake (g/day). c Subjects with baseline information on total ethanol intake. d Reference category. e Stable drinkers were defined as subjects who reported consuming equal total amounts of alcohol 5 years before baseline and at baseline. f Reference category: abstainers at baseline who reported having also abstained from alcohol 5 years before baseline.
no association was observed (heavy alcohol consumers vs. abstainers: RR ¼ 1.07, 95% CI: 0.45, 2.53). However, among women there were very few cases in the heavy alcohol consumption group (n ¼ 7). In order to investigate whether participants changed their drinking patterns because of preclinical manifestations of disease, we performed some additional analyses. Among stable alcohol users, we found a significantly increased risk among high alcohol consumers compared with abstainers in the total pancreatic cancer group (Table 3) . Among stable alcohol users in the MCPC group, the increased risk estimate was higher but of only borderline significance (RR ¼ 1.92, 95% CI: 0.99, 3.73), possibly because of small numbers of cases. When we restricted the analyses to subjects who reported having consumed more alcohol 5 years before baseline than at baseline (data not shown), we found a similar pattern, with an increased pancreatic cancer risk only in the highest category of ethanol intake (RR ¼ 2.36, 95% CI: 1.11, 5.03). This risk estimate was attenuated (RR ¼ 1.90) and became nonsignificant when we restricted the analyses to MCPC cases. For subjects who reported having consumed less alcohol 5 years before baseline than at baseline, no association was found (data not shown).
In addition, since the proportional hazards assumption was violated for ethanol intake, we calculated the interaction between ethanol intake and time and stratified the follow-up period into 2 periods. In the first part of the followup period, cases who consumed !30 g/day of ethanol had an approximately 2-fold increased cancer risk, both in the total case group and in the MCPC cases. This association was not observed during the second part of follow-up (Table 4) , although interaction with time was of borderline significance for MCPC cases (P interaction ¼ 0.05) and nonsignificant for all pancreatic cancer cases (P interaction ¼ 0.07). For stable drinkers, the difference between early and later follow-up was more pronounced (the interaction with time was statistically significant (P interaction ¼ 0.01); Table 4 ). When we stratified the follow-up period into 3 time periods Abbreviations: CI, confidence interval; RR, rate ratio. a Adjusted for age (years), sex, smoking (smoking status (current smoking: yes/no); number of cigarettes smoked per day; number of years of smoking), energy intake (kcal/day), body mass index (weight (kg)/height (m) 2 ), vegetable intake (g/day), and fruit intake (g/day). b Subjects with baseline information on total ethanol intake. c Reference category. d Stable drinkers were defined as subjects who reported consuming equal total amounts of alcohol 5 years before baseline and at baseline. e Reference category: abstainers at baseline who reported having also abstained from alcohol 5 years before baseline.
to investigate this further, we found a significantly increased risk for cases who consumed !30 g of ethanol daily during the first 5 years of follow-up; this risk gradually disappeared during the second and third parts of the follow-up period (data not shown), although the case numbers were quite small in different strata, especially in the third part of follow-up.
In addition to these analyses of total ethanol intake, we examined the intake of specific types of beverages, with total ethanol included in the multivariable-adjusted model. No clear associations were found between these beverages and pancreatic cancer risk (Table 5) , indicating no specific effect of any particular beverage type on top of the general effect of ethanol.
No evidence for a nonlinear association was found for any of the exposure variables in the analyses carried out using restricted cubic splines (no significant deviation from linearity using the Wald test (P > 0.05); data not shown). Furthermore, no evidence for interaction of alcohol consumption with smoking or folate was found (Table 6 ).
DISCUSSION
We found no association between low-to-moderate alcohol intake and risk of pancreatic cancer. We did, however, find a significantly increased risk for consumers of a high level of ethanol (!30 g/day).
So far, most cohort and case-control studies have provided little or no support for a causal relation between low-to-moderate alcohol use and pancreatic cancer risk Abbreviations: CI, confidence interval; RR, rate ratio. a Median intake in subcohort (see Table 1 for definition of subcohort). b Adjusted for age (years), sex, smoking (smoking status (current smoking: yes/no); number of cigarettes smoked per day; number of years of smoking), energy intake (kcal/day), body mass index (weight (kg)/height (m) (3, 12, 13, 15-18, 20, 23, 24) . If alcohol plays any role in the etiology of pancreatic cancer, it is likely to be among heavy drinkers (8) , which is in agreement with our findings. Two cohort studies suggested an increased risk with higher alcohol intake (19, 21) , and 2 other prospective studies found significantly increased risks (22, 25) . A cohort study carried out in Japan found a significantly increased risk among former drinkers, while a significant inverse association was found among current drinkers as compared with never drinkers (46) . Results of case-control studies have also been inconsistent (3), with most studies finding no association, while 2 studies found an increased risk of pancreatic cancer among heavy alcohol drinkers (47, 48) . Bagnardi et al. (44) conducted a meta-analysis of epidemiologic data and found no association between ethanol intake and pancreatic cancer (for intake of 100 g/day vs. abstention, RR ¼ 1.18, 95% CI: 0.94, 1.49). However, this meta-analysis was based on 13 case-control studies and only 4 cohort studies.
In our main analyses, the increased risk we found for high alcohol consumption was only present during the first part of follow-up; it was not observed during the second part. When we excluded from the analyses subjects who had changed their drinking habits before baseline, possibly because of preclinical manifestations of disease, the difference in effect estimates for early and later follow-up was more pronounced, showing a statistically significant interaction with time. This finding should be interpreted with some caution, since these analyses are based on low case numbers, especially in the highest category of ethanol intake during late follow-up among stable alcohol users in the MCPC group (n ¼ 8). In addition, it could be that recent alcohol intake is of greatest etiologic importance. Moreover, people decrease their alcohol intake or even stop drinking when they become older (49) . This could, in part, explain our findings. The food frequency questionnaire was tested for reproducibility by Goldbohm et al. (35) with repeated measurements at 5 annual intervals in independent samples of the cohort. For alcohol, the estimated decrease of the correlation coefficient between baseline and repeated measurement amounted to 0.02 per year, indicating a rather stable measurement during the first 5 years of follow-up. Nevertheless, it is possible that our food frequency questionnaire may not have been representative of the drinking habits of the participants during later follow-up. As far as we know, Michaud et al. (23) were the first to prospectively investigate an early or late effect of alcohol intake on pancreatic cancer risk. They performed analyses in 2 US populations, comparing past heavy users of alcohol with never users and then adding an 8-year lag period between measurement of diet and the follow-up period; in neither of these analyses did they find an increased risk of pancreatic cancer (23) . This should also be investigated in other observational studies with longer durations of follow-up. However, so far, studies that have observed an association between alcohol intake and pancreatic cancer risk and studies that have not observed an association have had similar follow-up times, ranging from 5 years to 20 years.
We did not observe any relation between intake of specific alcoholic beverages and pancreatic cancer risk. This is in agreement with most epidemiologic data, which suggest that it is ethanol itself and not the type of alcoholic beverage which plays a role in carcinogenesis (11) .
Many factors may contribute to the inconsistent results observed in the literature. Pancreatic cancer is particularly difficult to study in case-control studies, because poor survival leads to fewer direct interviews with cases, which could mean that investigators may have to rely on interviews with proxy respondents. In addition, half of the observational studies investigating the role of alcohol in the etiology of pancreatic cancer had low case numbers. Moreover, heavy alcohol drinkers may have lower participation rates than nondrinkers in both population-based case-control studies and cohort studies (44) .
In some animal studies, ethanol consumption slightly enhanced pancreatic carcinogenesis, but in other studies it did not demonstrate any effect on pancreatic carcinogenicity (8, (50) (51) (52) . It is still not clear, though, whether ethanol plays a role at initiation or at the promotion stage, since this has received limited attention among researchers in the field (10) .
The strengths of our study included the possibility of further restricting the analyses to MCPC cases and to stable alcohol drinkers. Selection bias due to differential follow-up is unlikely to have made a substantial contribution to our findings, since there was very little loss to follow-up (29) . The prospective design helped us avoid the need to use nextof-kin respondents.
A potential limitation is that abstainers and ex-drinkers were not separated in our study but were included in our reference category of abstainers. Since ex-drinkers may differ from abstainers in terms of pancreatic cancer risk, our estimated risks might have been biased in either direction. The proportion of ex-drinkers was probably small, since only 7.2% of the cohort members and 4.6% of the cases who consumed less than 1 alcoholic drink per month reported having consumed alcohol 5 years before baseline. Another limitation is that in some sensitivity analyses, the number of cases was too low to investigate relations in more depth-although, in comparison with other epidemiologic studies, our number of cases was substantial.
In conclusion, our findings suggest an increased risk of pancreatic cancer for persons with a high ethanol intake (!30 g/day). However, this increased pancreatic cancer risk was observed only during the first 7 years of follow-up.
